Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,361 stories, page 734 of 773

Advanced search

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

Sensorion announces leadership changes — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

Johnson & Johnson to acquire Shockwave Medical — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

News 16 April, 2026 Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

News 16 March, 2026 Elevara Medicines doses first patient in Phase 2b START-SYNERGY trial of ELV001 in rheumatoid arthritis patients with incomplete response to TNFi

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

CEO spotlight: CinCor's Marc de Garidel — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

CEO spotlight: Thierry Abribat's third straight win — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

Adapt or go extinct: Novameat unveils the ingredient that will save the global meat crisis — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

Abivax announces full year 2025 financial results and provides business updates — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

Sofinnova Partners closes €650M ($750M) Capital XI, greatly exceeding initial target to back early-stage healthcare deals

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

News 10 March, 2026 May Health raises $11.7M to advance its novel technology to treat PCOS-related infertility

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

In Memory of Denis Lucquin — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.comTier 2 · Direct publisher

News 16 February, 2026 Artios strengthens leadership team to accelerate late-stage development of potential first-in-class oncology pipeline

Sofinnova PartnersOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics Receives IND Clearance from the Taiwan Ministry of Health and Welfare for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead™ Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead™ Programs at the TIDES USA 2022

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC) | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysirnaomics.comTier 1 · Company source

Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment | Sirnaomics

SirnaomicsOriginal source

🇺🇸Jan 1, 1970Industrysingulargenomics.comTier 1 · Company source

Singular Genomics Launches the G4X Platform for High-Throughput In Situ Multiomics

Singular GenomicsOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.comTier 1 · Company source

Building bridges between humans and medical technology

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.comTier 1 · Company source

Prostate cancer: Facts, diagnosis, and treatment

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.comTier 1 · Company source

Healthcare Perspectives podcast

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.comTier 1 · Company source

Modeling the human liver

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.comTier 1 · Company source

Liver cancer: From diagnosis to personalized treatment

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.comTier 1 · Company source

Medical assistance robots: The robotics innovator

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.comTier 1 · Company source

Digital Twin What is a digital patient twin?

Siemens HealthineersOriginal source

🇩🇪Jan 1, 1970Devicessiemens-healthineers.comTier 1 · Company source

The code guardian

Siemens HealthineersOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

Dr. Stephen Scherer reappointed to Chief of Research at SickKids

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

Six SickKids scientists renewed as Canada Research Chairs

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

SickKids Research Chief Dr. Stephen Scherer receives King Salman International Award for Disability Research

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

SickKids receives national recognition for advancing nursing excellence

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

SickKids named world’s best children’s hospital for second year in a row

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

SickKids and Microsoft Canada join together to help teams diagnose faster, treat smarter and predict better

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

Plan ahead for University Avenue construction starting Sept. 21

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

National guideline aims to ease vaccination stress for children and families

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

How the KiCS research program is changing childhood cancer care

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

Celebrating 10 Years of PhotoVoice for Teens with Cancer at SickKids

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

Canadian group publishes guidelines for clinical genetic data sharing

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

Building the next generation of kidney researchers through community and collaboration

SickKids (Hospital for Sick Children) NewsOriginal source

🇨🇦Jan 1, 1970Researchsickkids.caTier 2 · Direct publisher

SickKids renewed as World Allergy Organization Center of Excellence

SickKids (Hospital for Sick Children) NewsOriginal source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Relationship with Customers

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Relationship with Business Partners

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Relationship with Society

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Relationship with Our Employees

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Sustainability-related Initiatives and memberships

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Promote proper use of medicines

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Improving affordability for patients in need

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Developing innovative therapies to address unmet needs

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Access to healthcare

Shionogi (IR News)Original source

🇯🇵Jan 1, 1970Industryshionogi.comTier 1 · Company source

Shionogi AMR Position Paper

Shionogi (IR News)Original source